首页> 外文期刊>药学学报(英文版) >In vitro and in vivo activity of D-serine in combination with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus
【24h】

In vitro and in vivo activity of D-serine in combination with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus

机译:D-丝氨酸联合β-内酰胺类抗生素对耐甲氧西林金黄色葡萄球菌的体外和体内活性

摘要

As D-amino acids play important roles in the physiological metabolism of bacteria,combination of D-amino acids with antibiotics may provide synergistic antibacterial activity.The aim of the study was to evaluate in vitro and in vivo activity of D-serine alone and in combination with β-lactams against methicillin-resistant Staphylococcus aureus (MRSA) strains,and to explore the possible sensitization mechanisms.The activity of D-serine,β-lactams alone and in combinations was evaluated both in vitro by standard MICs,time-kill curves and checkerboard assays,and in vivo by murine systemic infection model as well as neutropenic thigh infection model.An in vitro synergistic effect was demonstrated with the combination of D-serine and β-lactams against MRSA standard and clinical strains.Importantly,the combinations enhanced the therapeutic efficacy in the animal models as compared to β-lactam alone groups.Initial mechanism study suggested possible revision of D-alanine-D-alanine residue to D-alanine-D-serine in peptidoglycan by adding of D-alanine in the medium,which may cause decreased affinity to PBPs during transpeptidation.In conclusion,D-serine had synergistic activity in combination with β-lactams against MRSA strains both in vitro and in vivo.Considering the relatively good safety of D-serine alone or in combination with β-lactams,D-serine is worth following up as new anti-MRSA infection strategies.
机译:由于D-氨基酸在细菌的生理代谢中起着重要的作用,因此D-氨基酸与抗生素的结合可以提供协同的抗菌活性。本研究的目的是评估D-丝氨酸在体外和体内的活性。联合β-内酰胺类药物对耐甲氧西林金黄色葡萄球菌(MRSA)菌株的研究,并探讨可能的致敏机制。通过标准MICs在体外评估D-丝氨酸,β-内酰胺类化合物的活性和联合杀伤力曲线和棋盘检测,以及通过小鼠全身感染模型和中性粒细胞减少性大腿感染模型进行体内试验。D-丝氨酸和β-内酰胺类药物组合对MRSA标准品和临床菌株具有体外协同作用。重要的是,这些组合与单独使用β-内酰胺组相比,可增强动物模型的治疗效果。初始机制研究表明,D-丙氨酸-D-丙氨酸残基可能会被修饰为D-通过在培养基中添加D-丙氨酸可在肽聚糖中添加丙氨酸-D-丝氨酸,这可能会降低转肽过程中对PBP的亲和力。总之,D-丝氨酸与β-内酰胺类药物联合具有抗MRSA菌株的体外和体外协同作用。考虑到单独使用D-丝氨酸或与β-内酰胺组合使用都具有相对较高的安全性,值得将D-丝氨酸作为新的抗MRSA感染策略进行后续研究。

著录项

  • 来源
    《药学学报(英文版)》 |2019年第3期|496-504|共9页
  • 作者单位

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90502, USA;

    David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

    Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号